|
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study |
|
|
|
Titel: |
Talicabtagene autoleucel for relapsed or refractory B-cell malignancies: results from an open-label, multicentre, phase 1/2 study |
Auteur: |
Jain, Hasmukh Karulkar, Atharva Kalra, Devanshi Ravikumar, Smrithi Shah, Shreshtha Firfiray, Afrin Pendhari, Juber Jaiswal, Ankesh Kumar Khan, Aalia Sundharam, Manivasagam Vaibhaw, Anand Saroha, Ashish Rajyopadhye, Shreewardhan Basu, Moumita Asija, Sweety Chowdhury, Ambalika Beher, Rohit Banik, Ankit Dwivedi, Alka Purwar, Shalini Narula, Gaurav Banavali, Shripad Jain, Nitin Highfill, Steven L Stroncek, David Fry, Terry Melinkeri, Sameer Wilson, Lovin Agarwal, Narendra Aribandi, Anil Boyella, Pavan Kumar Shah, Nirali N Neelapu, Sattva S Sengar, Manju Purwar, Rahul |
Verschenen in: |
The Lancet. Haematology |
Paginering: |
Jaargang 12 () nr. 4 pagina's e282-e293 |
Jaar: |
2025 |
Inhoud: |
|
Uitgever: |
Elsevier Ltd |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|